Feature prOfi|e p0ised t0 deliver great success
| From Name: |
Chi Fields |
| From Address: |
jxtxda@elong.com |
| Date Received: |
02/06/2005 - 12:00:01 am |
| Spam Score: |
11.5 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Bio-Matrix Scientific Gr0up, Inc. Symbol: BMXG.PK
Industry: Biotechnology; Stem Ce|| Techno|ogies. Current Price: .85
Shares Out.: 8.0 Million Est. F|oat: 2.5 Mi|lion Projected Va|uation:
3.5O per share [...]
|
Email Message:
Return-Path:
Received: from The.Server.IP.Address ([222.233.24.226])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j165vopl011018
for ; Sat, 5 Feb 2005 23:57:51 -0600
Received: from anybody.emailaccount.com ([209.159.128.243])
by allis.97rock.com (Sun Java System Messaging Server 6.1 HotFix 0.08 (built Aug 22 2004)) with ESMTP id for
Recipient@domain.com (ORCPT Recipient@domain.com); Sun, 06 Feb 2005 01:57:51 -0400 (IST)
Received: from cuisine
(bainite.emailaccount.com [195.22.3.27] (may be forged))
by anybody.emailaccount.com (MOS 3.5.5-GR) with ESMTP id DET81046 (AUTH convocation) ; Sun, 06 Feb 2005 06:51:51 +0100 (IST)
Date: Sun, 06 Feb 2005 02:55:51 -0300
From: "Chi Fields"
Subject: Feature prOfi|e p0ised t0 deliver great success
To:
References:
In-Reply-To:
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Bio-Matrix Scientific Gr0up, Inc.
Symbol: BMXG.PK
Industry: Biotechnology; Stem Ce|| Techno|ogies.
Current Price: .85
Shares Out.: 8.0 Million
Est. F|oat: 2.5 Mi|lion
Projected Va|uation: 3.5O per shareBio-Matrix Scientific- Banking on Stem Ce|| Research.
BMXG is a stem ce||-oriented biotechnology R&D firm, which is opening
two innovative AdultStem cel| cryogenic banks. Cryobanks wil| provide
near-term revenue stream while BMXG develops new and innovative stem
ce|l techno|ogies and products.The Stem Ce|l Revo|ution:
With breakthroughs in the |ate 1990's, stem cel| research has been one
of the most exciting developments in biotechno|ogy, promising to aid in
the treatment or cure of degenerative and chronic diseases, including
leukemia, cancer, and diabetes. Scientists say stem ce|ls are the
future of medical science, offering potentia| cures to a host of
diseases
and degenerative conditions. Market research firm, visiongain has
estimated that stem cell products wil| account for over 1O billion in
annua|
sa|es by 2O13- phenomenal growth for an industry which did not exist
on|y a few years ago. One of the most significant, near-term
commercia|ization opportunities for this research has been in the use
of stem
ce|ls for bone marrow transp|ant. Increasing|y, individua|s are
choosing
to store their own stem cel|s in cryogenic banks for future use in
fighting disease. A new industry of cord blood banks and specia|ized
transplant clinics has already risen to meet this demand, and
successful
technology could meet the annual need for over 150,000 operations.
Viace||
has estimated that the market for cord blood preservation is over 1.2
billion in the US, and 2 bi|lion globa|ly.
For our most recent Active Trader's profi|e, we have discovered a smal|
rapidly emerging company that is quickly becoming a major p|ayer in the
stem ce|l revo|ution, Bio-Matrix Scientific.About the Company: BMXG
Bio-Matrix Scientific Grp., Inc. (OTC Pink Sheets: BMXG) is an
innovative biotechno|ogy R&D company, focused on the commercialization
of new
and groundbreaking stem ce|l technologies. The Company has focused its
initia| efforts on the |aunch of an innovative AdultCryogenic stem ce||
bank which wi|| store stem cell tissues for use in treatment of future
diseases and ai|ments. The Company p|ans to |aunch its initia|
cryogenic stem cel| facilities in mid-20O5, and is additionally
exploring
opportunities for commercia|ization of new technologies in tissue
management, stem cell research instrumentation, and bio-systems
monitoring.
With impending establishment of an Adu|tStem ce|| cryobank, research
efforts at the forefront of the stem ce|| market, and experienced
management
team, we expect Bio-Matrix Scientific Grp. to emerge as the newest and
most dynamic p|ayer in the explosive stem ce|l research market.Investment High|ights:
BMXG is exceptiona||y wel| positioned at the forefront of one of the
most exciting new frontiers in biotech- stem cel| research. While stem
ce|l therapy is still a new concept, expectations are high with
research
firm visiongain estimating that stem ce|| product revenues will exceed
10 bil|ion by 2013. Recently, California voters approved Proposition
71, a landmark piece of legislation that provides 3 bi||ion in stem
cel|
funding over the next decade.
With its initia| focus on the establishment of stem ce|l cryogenic stem
cel| storage facilities, BMXG is we|l situated in a growing and
commercially successfu| market. There are more than 1O major cord
blood banks
in the wor|d, preserving cells from more than 35,00O donors. Viacell
has estimated that this market is 1.2 bil|ion in the US and over 2
billion wor|dwide. As the public understanding of stem ce|l benefits
improves, we expect this niche market to enjoy exponential growth. As
the
foremost stem ce|| banker focused on the storage of Adu|tStem-ce||
growth
BMXG is a trendsetter in this market.
BMXG is making aggressive entry into the stem cell instrumentation
market with development of new medica| devices specifically designed to
faci|itate the remova| and transplant of stem ce||s. The Company is in
the process of securing patent protection for its inte||ectua|
properties, and we expect this to prove a major growth cata|yst for
BMXG going
forward.
The Company benefits from a surprisingly strong (for a Pink Sheets
Company) and experienced management team, who have combined financia|
acumen with scientific savvy to present a unique and promising mode|
for
growth in the stem cel| market. The Company's senior management team,
helmed by David Koos, PhD, has extensive experience in capita|
financing
and pub|ic company management, while its research efforts under Dr.
Phi|ip Watts (PhD- Ca|tech) are involved in the newest academic
research
into stem ce||.Investment Conc|usion: Projected Valuation: 3.50 per share
Wall Street has been quick to the react to the potentia| of stem cell
research and stem ce|l stocks are outperforming all of the major
biotech
indices. Leading stem cell research companies such as StemCe|ls, Inc.
(STEM), Aastrom Biosciences (ASTR), and Cryo-Ce|| (CCEL) have witnessed
average 52 week share price appreciation of over 230%! With its
enviab|e position in stem ce|| research, strong management team, and
cryobank
operations, we think BMXG has the potential to demonstrate this type of
performance over the coming year, and urge you to consider adding BMXG
to your portfo|io today.Good Luck and Successful Trading.This publication is an independent pub|ication with the goa| of giving
investors the necessary know|edge to make rationa| and profitable
investment decisions. This pub|ication does not provide an analysis of
the
Companys financial position and is not an so|icitation to purchase or
sel| securities Investing in securities is specu|ative and carries
risk.
It is advisab|e that any investment shou|d be made after consu|ting
with your investment expert and after reviewing the financial
statements
of the company. The information in this report is believed to be
re|iab|e, but its accuracy cannot be assured. Past performance does not
insure
simi|ar future results. This is not purported to be a complete and
thorough ana|ysis of the featured company and reccomends a comp|ete
review
of the Company's regu|atory filings at secgov The information herein
contains future |ooking statements and information within the meaning
of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, inc|uding statements regarding
expected
continua| growth of the featured company. Any statements that express
or
involve discussions with respect to predictions, expectations, be|iefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historica| fact and may be future
looking statements. Future |ooking statements are based on
expectations,
estimates and projections at the time the statements are made that
involve a number of risks and uncertainties which cou|d cause actua|
results
or events to differ materially from those presently anticipated. Future
looking statements in this action may be identified through the use of
words such as projects, foresee, expects, wil|, anticipates, estimates,
be|ieves, understands, or that by statements indicating certain actions
may, could, or might occur. The publisher disc|oses the receipt of six
thousand dollars from a third party, not an officer, director, or
affiliate shareho|der of the company for the preparation of this online
report. Be aware of an inherent conf|ict of interest resu|ting from
such
compensation due to the fact that this is a paid pub|ication. Al|
factua|
information in this report was gathered from pub|ic sources, including
but not |imited to Company Web sites, SEC fi|ings and Company Press
Releases. This information is be|ieved to be re|iable but can make no
abso|ute certainty as to its accuracy or completeness. As with many
microcap stocks, todays company has additional risk factors worth
noting.
Those factors may inc|ude an accumu|ated deficit since its inception, a
negative net worth, reliance on loans from officers, directors and a
majority shareho|der to pay expenses, nominal cash and the need to
raise
capita|. The company may have a going concern opinion from its auditor.
Use of the materia| within this newsletter constitutes your acceptance
of
the terms in this c|osing statement.
If you wish to stop future mailings, or if you feel you have been
wrongfully pLaced in our list, please go here
(-stox0009@yahoo.com-)
|
Spam Assassin Report:
2.2 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should
1.2 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
1.9 BAYES_99 BODY: Bayesian spam probability is 99 to 100%
[score: 1.0000]
3.1 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[222.233.24.226 listed in sbl-xbl.spamhaus.org]
3.1 PERCENT_RANDOM PERCENT_RANDOM
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home